Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Capital Reinvestment Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A capital reinvestment ratio. Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥109.83 Million) in capital expenditures (CN¥6.99 Million). Check 600613 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Capital reinvestment ratio of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1998 to 2025. This chart tracks Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's Capital Reinvestment Ratio across 22 annual periods. Also explore Shanghai Shenqi Pharmaceutical Investmen net asset momentum to track the company's year-over-year net asset growth rate.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Capital Reinvestment Ratio by Year (1998–2025)
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A capital reinvestment ratio by year from 1998 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Shenqi Pharmaceutical Investmen.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | CN¥124.47 Million | CN¥33.22 Million | ▲ +52.4% |
| 2024 | 0.18x | CN¥207.79 Million | CN¥36.39 Million | ▲ +54.0% |
| 2023 | 0.11x | CN¥215.59 Million | CN¥24.51 Million | ▲ +36.2% |
| 2022 | 0.08x | CN¥319.23 Million | CN¥26.64 Million | ▼ -82.1% |
| 2021 | 0.47x | CN¥184.26 Million | CN¥85.96 Million | ▼ -52.0% |
| 2020 | 0.97x | CN¥99.10 Million | CN¥96.31 Million | ▲ +62.0% |
| 2019 | 0.60x | CN¥128.28 Million | CN¥76.96 Million | ▼ -19.2% |
| 2018 | 0.74x | CN¥148.53 Million | CN¥110.25 Million | ▼ -54.3% |
| 2017 | 1.62x | CN¥66.99 Million | CN¥108.84 Million | ▼ -97.8% |
| 2016 | 75.16x | CN¥570.41K | CN¥42.87 Million | ▲ +3320.6% |
| 2015 | 2.20x | CN¥30.12 Million | CN¥66.18 Million | ▲ +195.5% |
| 2013 | 0.74x | CN¥74.75 Million | CN¥55.58 Million | ▲ +4176.6% |
| 2010 | 0.02x | CN¥33.04 Million | CN¥574.38K | ▼ -85.3% |
| 2009 | 0.12x | CN¥7.69 Million | CN¥907.90K | ▲ +741.2% |
| 2008 | 0.01x | CN¥25.26 Million | CN¥354.57K | ▼ -75.2% |
| 2007 | 0.06x | CN¥16.01 Million | CN¥906.84K | ▼ -47.0% |
| 2005 | 0.11x | CN¥32.72 Million | CN¥3.50 Million | ▼ -91.6% |
| 2004 | 1.27x | CN¥4.96 Million | CN¥6.29 Million | ▲ +808.9% |
| 2003 | 0.14x | CN¥4.52 Million | CN¥629.83K | ▼ -31.0% |
| 2002 | 0.20x | CN¥16.02 Million | CN¥3.24 Million | ▼ -53.8% |
| 2000 | 0.44x | CN¥26.85 Million | CN¥11.76 Million | ▲ +2282.2% |
| 1998 | 0.02x | CN¥72.67 Million | CN¥1.34 Million | — |